Energy Production

Product Purpose:

• Weight Loss and Fat Reduction: Reduces fat mass accumulation in diet-induced obese and ob/ob mice without affecting appetite or requiring physical activity, achieving up to 18% body weight loss over 28 days at 50 mg/kg twice daily.

• Improved Insulin Sensitivity: Enhances glucose tolerance and insulin signaling, reducing blood insulin levels and improving metabolic parameters in models of T2D and metabolic syndrome.

• Enhanced Exercise Endurance: Increases oxidative muscle fibers and mitochondrial density, improving running capacity by 45–70% in sedentary mice, offering potential for studying muscle function in aging or sedentary populations.

• Mitochondrial Function: Boosts cellular respiration and ATP production in skeletal muscle cell lines (e.g., C2C12 myocytes), supporting metabolic efficiency and energy expenditure.

• Cardioprotective Effects: Preserves cardiac contractility in models of heart failure and ischemia-reperfusion injury, suggesting potential for cardiovascular research.

• Potential Neuroprotection: Preliminary studies indicate applications in Alzheimer’s and Parkinson’s diseases by improving mitochondrial function in neuronal cells, though evidence is limited.

• Kidney Protection: Indirectly supports renal health by improving metabolic parameters linked to T2D, potentially reducing kidney stress in obesity-related conditions.

Research Use Only:

SLU-PP-332  is intended strictly for in vitro testing and laboratory experimentation. It’s not intended for human or animal medical use. It’s not a drug, food, or cosmetic and should not be misbranded, misused, or mislabeled as such.